Difficulty: Medium
Average Score: 86%
Practice
The client is diabetic and is given a non-cardio-selective beta blocker. What might happen to the blood sugars?
Correct answer
B
Rationale
The correct answer is B) The blood sugar drops due to impaired production of glucose from glycogen when a diabetic client is given a non-cardio-selective beta blocker.
When a non-cardio-selective beta blocker is administered, it blocks the beta-2 receptors in the liver, inhibiting glycogenolysis and gluconeogenesis. This leads to a decrease in the production of glucose from glycogen stores in the liver, causing a drop in blood sugar levels.
Option A is incorrect because the breakdown of glycogen would actually lead to a decrease in blood sugar levels, not an increase. Option C is incorrect because beta blockers do have an effect on blood sugar levels in diabetic individuals. Option D is incorrect because beta blockers do not increase cellular uptake of glucose; instead, they decrease the production of glucose.
In an educational context, it is important for healthcare professionals to understand the effects of medications on different physiological processes, especially in patients with comorbid conditions like diabetes. This knowledge helps in making informed decisions about medication management to ensure patient safety and optimal outcomes.
When a non-cardio-selective beta blocker is administered, it blocks the beta-2 receptors in the liver, inhibiting glycogenolysis and gluconeogenesis. This leads to a decrease in the production of glucose from glycogen stores in the liver, causing a drop in blood sugar levels.
Option A is incorrect because the breakdown of glycogen would actually lead to a decrease in blood sugar levels, not an increase. Option C is incorrect because beta blockers do have an effect on blood sugar levels in diabetic individuals. Option D is incorrect because beta blockers do not increase cellular uptake of glucose; instead, they decrease the production of glucose.
In an educational context, it is important for healthcare professionals to understand the effects of medications on different physiological processes, especially in patients with comorbid conditions like diabetes. This knowledge helps in making informed decisions about medication management to ensure patient safety and optimal outcomes.